UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response

Leukemia, 2004-09, Vol.18 (9), p.1491-1498

2004

Volltextzugriff (PDF)

Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants

Thrombosis and haemostasis, 1995-10, Vol.74 (4), p.1120

1995

Volltextzugriff (PDF)

Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma

Leukemia, 2000-09, Vol.14 (9), p.1667-1677

2000

Volltextzugriff (PDF)

Tumor B Cells From Non-Hodgkin’s Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis

Blood, 1998-04, Vol.91 (8), p.2875-2885

1998

Volltextzugriff (PDF)

Identification of a leukemic counterpart of the plasmacytoid dendritic cells

Blood, 2001-05, Vol.97 (10), p.3210-3217

2001

Volltextzugriff (PDF)

Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin's lymphoma

Leukemia, 1999-09, Vol.13 (9), p.1428-1433

1999

Volltextzugriff (PDF)

Preparation of purified lymphoma cells suitable for therapy

Cytotherapy (Oxford, England), 2004-06, Vol.6 (3), p.235-243

2004

Volltextzugriff (PDF)

Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts

European journal of immunology, 2004-02, Vol.34 (2), p.418-426

2004

Volltextzugriff (PDF)

Survival of DNA HLA-DR typed and matched cadaver kidney transplants

The Lancet (British edition), 1991-08, Vol.338 (8765), p.461-463

1991

Volltextzugriff (PDF)

Microsatellites in the HLA region: HLA prediction and strategies for bone marrow donor registries

Transplantation proceedings, 2001-02, Vol.33 (1-2), p.491-492

2001

Volltextzugriff (PDF)

Beneficial effect of one HLA haplo- or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients

Transplantation, 1995-03, Vol.59 (5), p.719

1995

Volltextzugriff (PDF)

False-negative results in anti-HLA antibody detection by Sangstat ELISA: complement dependent cytotoxicity is not yet obsolete

Transplantation, 1996-11, Vol.62 (10), p.1533

1996

Volltextzugriff (PDF)

Anti-HLA class I reimmunization after one HLA semi-identical blood transfusion in non-naive patients on a waiting list for a first renal allograft

Transplantation proceedings, 1998-09, Vol.30 (6), p.2854-2854

1998

Volltextzugriff (PDF)

From the Study of Tumor Cell Immunogenicity to the Generation of Antitumor Cytotoxic Cells in Non-Hodgkin's Lymphomas

Leukemia & lymphoma, 2000-07, Vol.38 (3-4), p.247-263

2000

Volltextzugriff (PDF)

Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants

Transplantation, 1993-04, Vol.55 (4), p.782

1993

Volltextzugriff (PDF)

DNA HLA-DR typing results of 4000 kidney transplants

Transplantation, 1993-04, Vol.55 (4), p.778

1993

Volltextzugriff (PDF)

Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes

Biochemical journal, 1983-11, Vol.216 (2), p.385-392

1983

Volltextzugriff (PDF)

The major histocompatibility complex as self-referential

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2003-06, Vol.10 (3), p.209

Bensa, J C

2003

Volltextzugriff (PDF)

HCV-Infection in Blood Donors: Association between Anti-HCV Core IgM Antibodies and Serum HCV RNA

Vox sanguinis, 1996-01, Vol.70 (3), p.139-143

1996

Volltextzugriff (PDF)

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas

Blood, 2003-02, Vol.101 (3), p.949-954

2003

Volltextzugriff (PDF)

Relationships Between Susceptibility to LAK Cell-Mediated Lysis, Conjugate Formation and Expression of Adhesion Molecules in B-Cell Derived Non-Hodgkin's Lymphomas

Leukemia & lymphoma, 1997-12, Vol.28 (1-2), p.133-143

1997

Volltextzugriff (PDF)

One HLA haplo-identical transfusion in first renal allograft recipients : effect on alloimmunisation, acute rejection episodes, and graft survival

Transplantation proceedings, 1995-08, Vol.27 (4), p.2457-2458

1995

Volltextzugriff (PDF)

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin’s lymphomas

Experimental hematology, 1999-03, Vol.27 (3), p.479-488

1999

Volltextzugriff (PDF)

Malignant B lymphocytes from non‐Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: An important role of co‐stimulatory molecules CD80 (B7‐1) and CD86 (B7‐2) in stimulation by tumor cells

European journal of immunology, 1995-12, Vol.25 (12), p.3332-3341

1995

Volltextzugriff (PDF)

T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma : reactivity toward the malignant clone

Blood, 1990-03, Vol.75 (5), p.1154-1162

1990

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(125)
Buchkapitel
(10)
Bücher
(4)
Texte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(84)
Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Biological And Medical Sciences
(41)
Female
(40)
Male
(36)
Medical Sciences
(36)
Middle Aged
(35)
Adult
(33)
Hematology
(31)
Aged
(22)
Hematologic And Hematopoietic Diseases
(18)
Immunology
(17)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(17)
Adolescent
(13)
Child
(13)
Animals
(11)
B-Lymphocytes - Immunology
(10)
Clinical Neurology
(10)
Lymphoma, B-Cell - Pathology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response

Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants

Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma

Tumor B Cells From Non-Hodgkin’s Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis

Identification of a leukemic counterpart of the plasmacytoid dendritic cells

Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin's lymphoma

Preparation of purified lymphoma cells suitable for therapy

Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts

Survival of DNA HLA-DR typed and matched cadaver kidney transplants

Microsatellites in the HLA region: HLA prediction and strategies for bone marrow donor registries

Beneficial effect of one HLA haplo- or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients

False-negative results in anti-HLA antibody detection by Sangstat ELISA: complement dependent cytotoxicity is not yet obsolete

Anti-HLA class I reimmunization after one HLA semi-identical blood transfusion in non-naive patients on a waiting list for a first renal allograft

From the Study of Tumor Cell Immunogenicity to the Generation of Antitumor Cytotoxic Cells in Non-Hodgkin's Lymphomas

Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants

DNA HLA-DR typing results of 4000 kidney transplants

Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes

The major histocompatibility complex as self-referential

HCV-Infection in Blood Donors: Association between Anti-HCV Core IgM Antibodies and Serum HCV RNA

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas

Relationships Between Susceptibility to LAK Cell-Mediated Lysis, Conjugate Formation and Expression of Adhesion Molecules in B-Cell Derived Non-Hodgkin's Lymphomas

One HLA haplo-identical transfusion in first renal allograft recipients : effect on alloimmunisation, acute rejection episodes, and graft survival

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin’s lymphomas

Malignant B lymphocytes from non‐Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: An important role of co‐stimulatory molecules CD80 (B7‐1) and CD86 (B7‐2) in stimulation by tumor cells

T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma : reactivity toward the malignant clone

Suchergebnisse filtern